SECsense Logo

Cargo Therapeutics, Inc. 8-K Report: Key Financial Insights (January 2025)

$CRGX
Form 8-K
Filed on: 2025-01-10
Source
Cargo Therapeutics, Inc. 8-K Report: Key Financial Insights (January 2025)

Based on the provided section of the financial report, here are the key insights and information extracted:

  1. Company Information:
  • Name: Cargo Therapeutics, Inc.
  • Address: 835 Industrial Road, Suite 400, San Carlos, CA 94070
  • Contact Number: (650) 499-8950
  • CIK Number: 0001966494
  • SEC Central Index Key (CIK): 0001966494
  1. Filing Details:
  • Filing Type: 8-K (current report)
  • Filing Date: January 10, 2025
  • Period Covered: The report covers the date January 10, 2025.
  1. Company Identifier:
  • Stock Ticker: CRGX
  • Exchange: NASDAQ
  • Common Stock Par Value: $0.001 per share
  1. Financial Reporting Framework:
  • The document is structured in XBRL (eXtensible Business Reporting Language), which is a standardized format for financial reporting.
  1. Regulatory Information:
  • The report is filed under SEC regulations with the reference to its schema, indicating compliance with XBRL requirements for electronic filing.
  1. Tax Identification:
  • EIN: 84-4080422

This information provides a snapshot of Cargo Therapeutics, Inc. as of the filing date, highlighting its operational and financial reporting details. The 8-K filing typically contains important events that shareholders should be aware of, although specifics on the content of the 8-K are not provided in this excerpt.